Start › Niedrobnokomórkowy rak płuca › Illinois › Cicero
Badania kliniczne dla Niedrobnokomórkowy rak płuca w mieście Cicero, IL
24 badań dla Niedrobnokomórkowy rak płuca szuka uczestników w ośrodkach w mieście Cicero i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekrutacjaFaza 3
- Edward Hines Jr VA Hospital, Hines · 4 mi dalej
- Advocate Christ Medical Center, Oak Lawn · 9 mi dalej
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekrutacjaFaza 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi dalej
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
RekrutacjaFaza 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · 10 mi dalej
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekrutacjaFaza 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi dalej
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
RekrutacjaFaza 2
- Hope and Healing Clinical Research, Hinsdale · 10 mi dalej
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RekrutacjaFaza 3
- Advocate Christ Medical Center, Oak Lawn · 9 mi dalej
- Hope and Healing Cancer Services, Hinsdale · 10 mi dalej
- Endeavor Health, Elmhurst · 10 mi dalej
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
RekrutacjaFaza 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi dalej
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
RekrutacjaFaza 3
- Research Site, Hinsdale · 10 mi dalej
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
RekrutacjaFaza 3
- Research Site, Hinsdale · 10 mi dalej
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekrutacjaFaza 2/3
- Loyola University Medical Center, Maywood · 5 mi dalej
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
RekrutacjaFaza 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi dalej
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekrutacjaFaza 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi dalej
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
RekrutacjaFaza 3
- Research Site, Hinsdale · 10 mi dalej
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RekrutacjaFaza 3
- Research Site, Hinsdale · 10 mi dalej
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
RekrutacjaFaza 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi dalej
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RekrutacjaFaza 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · 10 mi dalej
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi dalej
- Edward Hines Jr VA Hospital, Hines · 4 mi dalej
- Loyola University Medical Center, Maywood · 5 mi dalej
- i 2 więcej
MYLUNG Consortium Part 3: Observational Study
RekrutacjaBadanie obserwacyjne
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi dalej
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- Edward Hines Jr VA Hospital, Hines · 4 mi dalej
- Loyola University Medical Center, Maywood · 5 mi dalej
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi dalej
- i 3 więcej
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- Edward Hines Jr VA Hospital, Hines · 4 mi dalej
- Loyola University Medical Center, Maywood · 5 mi dalej
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi dalej
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2/3
- Loyola University Medical Center, Maywood · 5 mi dalej
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi dalej
- Advocate Christ Medical Center, Oak Lawn · 9 mi dalej
- i 2 więcej
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekrutacjaBadanie obserwacyjne
- Advocate Christ Medical Center, Oak Lawn · 9 mi dalej
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mi dalej
- Advocate High Tech Medical Park, Palos Heights · 12 mi dalej
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Rekrutacja
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4 mi dalej
GEMINI-NSCLC: NSCLC Biomarker Study
RekrutacjaBadanie obserwacyjne
- Hope and Healing Cancer Services, Hinsdale · 10 mi dalej
Badania dla Niedrobnokomórkowy rak płuca w innych miastach
- Houston, TX145 badań
- New York City, NY120 badań
- Arlington, VA104 badań
- Nashville, TN97 badań
- Boston, MA90 badań
- Los Angeles, CA87 badań
- St. Louis, MO73 badań
- Chicago, IL61 badań
- Baltimore, MD60 badań
- San Antonio, TX59 badań
- Columbus, OH56 badań
- Washington, DC55 badań
Inne badania w mieście Cicero
- Rak płuc17 badań
- Rak prostaty14 badań
- Nowotwory (wszystkie typy)13 badań
- Ostra białaczka szpikowa11 badań
- Rak piersi11 badań
- Rak jelita grubego i odbytnicy10 badań
- Rak pęcherza moczowego8 badań
- Nowotwór przerzutowy7 badań
- Czerniak7 badań
- Choroby układu sercowo-naczyniowego7 badań
- Chłoniak Burkitta6 badań
- Rak płaskonabłonkowy głowy i szyi6 badań
Źródło: ClinicalTrials.gov, dane pobrane 5 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.